Ekso Bionics Holdings, Inc. (EKSO)
USD 0.63
(-11.99%)
USD 0.63
(-11.99%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -15.11 Million USD | 2.85% |
| 2022 | -15.55 Million USD | -12.5% |
| 2021 | -13.82 Million USD | -7.54% |
| 2020 | -12.85 Million USD | 22.72% |
| 2019 | -16.63 Million USD | 38.44% |
| 2018 | -27.03 Million USD | 14.49% |
| 2017 | -31.61 Million USD | -14.59% |
| 2016 | -27.58 Million USD | -27.94% |
| 2015 | -21.56 Million USD | -28.39% |
| 2014 | -16.79 Million USD | -136525.45% |
| 2013 | -12.29 Thousand USD | 99.91% |
| 2012 | -14.24 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.33 Million USD | 28.29% |
| 2024 Q3 | -2.63 Million USD | -13.02% |
| 2024 Q1 | -3.25 Million USD | 5.6% |
| 2023 Q3 | -2.93 Million USD | 31.58% |
| 2023 Q4 | -3.44 Million USD | -17.67% |
| 2023 FY | -15.11 Million USD | 2.85% |
| 2023 Q1 | -4.44 Million USD | -0.27% |
| 2023 Q2 | -4.28 Million USD | 3.69% |
| 2022 Q4 | -4.43 Million USD | -21.4% |
| 2022 FY | -15.55 Million USD | -12.5% |
| 2022 Q1 | -4.23 Million USD | 6.92% |
| 2022 Q3 | -3.65 Million USD | -13.16% |
| 2022 Q2 | -3.22 Million USD | 23.79% |
| 2021 Q4 | -4.55 Million USD | -63.21% |
| 2021 Q3 | -2.78 Million USD | 16.7% |
| 2021 Q2 | -3.34 Million USD | -6.66% |
| 2021 Q1 | -3.13 Million USD | -4.74% |
| 2021 FY | -13.82 Million USD | -7.54% |
| 2020 Q2 | -3.09 Million USD | 35.33% |
| 2020 Q4 | -2.99 Million USD | -23.79% |
| 2020 Q3 | -2.42 Million USD | 21.7% |
| 2020 FY | -12.85 Million USD | 22.72% |
| 2020 Q1 | -4.78 Million USD | -68.4% |
| 2019 Q3 | -3.79 Million USD | 25.66% |
| 2019 Q1 | -4.91 Million USD | 4.42% |
| 2019 Q2 | -5.09 Million USD | -3.79% |
| 2019 Q4 | -2.83 Million USD | 25.09% |
| 2019 FY | -16.63 Million USD | 38.44% |
| 2018 Q2 | -7.18 Million USD | 16.58% |
| 2018 FY | -27.03 Million USD | 14.49% |
| 2018 Q4 | -5.13 Million USD | 15.67% |
| 2018 Q3 | -6.09 Million USD | 15.18% |
| 2018 Q1 | -8.61 Million USD | -8.39% |
| 2017 Q3 | -7.06 Million USD | 16.47% |
| 2017 Q4 | -7.94 Million USD | -12.45% |
| 2017 FY | -31.61 Million USD | -14.59% |
| 2017 Q1 | -8.14 Million USD | -21.83% |
| 2017 Q2 | -8.45 Million USD | -3.91% |
| 2016 Q2 | -7.39 Million USD | -11.35% |
| 2016 FY | -27.58 Million USD | -27.94% |
| 2016 Q4 | -6.68 Million USD | 2.68% |
| 2016 Q3 | -6.86 Million USD | 7.17% |
| 2016 Q1 | -6.64 Million USD | 0.15% |
| 2015 Q1 | -4.09 Million USD | 15.76% |
| 2015 FY | -21.56 Million USD | -28.39% |
| 2015 Q4 | -6.65 Million USD | -28.39% |
| 2015 Q3 | -5.18 Million USD | 8.06% |
| 2015 Q2 | -5.63 Million USD | -37.67% |
| 2014 Q3 | -3.73 Million USD | 13.43% |
| 2014 Q2 | -4.31 Million USD | -10.77% |
| 2014 Q1 | -3.89 Million USD | -63963.93% |
| 2014 FY | -16.79 Million USD | -136525.45% |
| 2014 Q4 | -4.85 Million USD | -30.2% |
| 2013 FY | -12.29 Thousand USD | 99.91% |
| 2013 Q4 | -6075.00 USD | -306.9% |
| 2013 Q1 | -4368.00 USD | -145.81% |
| 2013 Q2 | -23.19 Thousand USD | -431.0% |
| 2013 Q3 | -1493.00 USD | 93.56% |
| 2012 Q3 | -1252.00 USD | 74.42% |
| 2012 FY | -14.24 Million USD | 0.0% |
| 2012 Q2 | -4895.00 USD | 0.0% |
| 2012 Q4 | -1777.00 USD | -41.93% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 73.795% |
| AngioDynamics, Inc. | -97.71 Million USD | 84.535% |
| AtriCure, Inc. | -26.68 Million USD | 43.365% |
| Avinger, Inc. | -16.63 Million USD | 9.155% |
| Azenta, Inc. | -73.12 Million USD | 79.334% |
| BioLife Solutions, Inc. | -70.82 Million USD | 78.663% |
| The Cooper Companies, Inc. | 533.1 Million USD | 102.835% |
| Daxor Corporation | -177.07 Thousand USD | -8434.237% |
| Femasys Inc. | -14.5 Million USD | -4.16% |
| GlucoTrack, Inc. | -7.1 Million USD | -112.725% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 897.888% |
| Hologic, Inc. | 882.6 Million USD | 101.712% |
| ICU Medical, Inc. | 22.82 Million USD | 166.208% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 100.855% |
| KORU Medical Systems, Inc. | -10.26 Million USD | -47.147% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 140.753% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -118.997% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -118.997% |
| Masimo Corporation | 136.5 Million USD | 111.071% |
| Microbot Medical Inc. | -9.85 Million USD | -53.343% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 202.978% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 112.193% |
| Nephros, Inc. | -1.59 Million USD | -848.65% |
| NovoCure Limited | -232.87 Million USD | 93.511% |
| NEXGEL, Inc. | -3.47 Million USD | -334.628% |
| NEXGEL, Inc. | -3.47 Million USD | -334.628% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 85.3% |
| OraSure Technologies, Inc. | 54.07 Million USD | 127.944% |
| Pro-Dex, Inc. | 7.17 Million USD | 310.679% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 65.319% |
| Predictive Oncology Inc. | -13.92 Million USD | -8.553% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -454.705% |
| QuidelOrtho Corporation | 139.1 Million USD | 110.864% |
| Repligen Corporation | 54.57 Million USD | 127.69% |
| Sanara MedTech Inc. | -4.21 Million USD | -258.516% |
| STAAR Surgical Company | 28.09 Million USD | 153.785% |
| Sharps Technology, Inc. | -10.12 Million USD | -49.23% |
| Utah Medical Products, Inc. | 16.77 Million USD | 190.076% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 82.221% |
| Jin Medical International Ltd. | 2.86 Million USD | 627.053% |